Technology News and Research

RSS

Medisafe 1 Technologies demonstrates syringe locking device at Israel's National Ministry of Health

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company conducted an official demonstration of its barcoded syringe locking device at Israel's National Ministry of Health.

9 Dec 2010

Media examines efforts to protect patients in Africa from counterfeit medications

HP and the African social enterprise mPedigree on Monday announced a new service that will enable patients in Ghana and Nigeria to verify the authenticity of their medications, Fast Company reports. "Counterfeit drugs are estimated to be a $75-billion-per-year business, [and are] implicated in the deaths of something like 700,000 people around the world annually," according to the article (Zax, 12/6).

9 Dec 2010

VIRxSYS presents study results of VRX1116 at HIV DART 2010

VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies, today presented results from a study of VRX1116 at HIV DART 2010 in Los Cabos, Mexico, showing that vaccinated monkeys challenged with highly pathogenic simian immunodeficiency virus achieve sustained viral load reduction, preservation of the immune system and increased survival compared to controls.

9 Dec 2010

Nottingham researchers develop new 'score' to detect heart disease in younger people

Experts at The University of Nottingham have developed a new 'score' to help GPs detect heart disease in younger people - before it damages their health.

9 Dec 2010

Exergen's TemporalScanner demonstrates accuracy in temperature assessment for surgical patients

Temperatures taken orally or by temporal artery thermometry "are an accurate means of temperature assessment for adult patients undergoing colorectal or gynecology surgery," according to analysis published by the Journal of PeriAnesthesia Nursing. Accurate temperature readings are necessary to determine when to intervene for patients at all stages of their hospitalizations but especially during and immediately after surgical procedures to avoid post-operative complications.

9 Dec 2010

Bioheart group to advance BRIDGE TO RECOVERY clinical trial

Bioheart, Inc. announced today that at the American Heart Association Annual Meeting, it finalized the formation of a working group. The group's focus is to advance a BRIDGE TO RECOVERY clinical trial, combining a left ventricle assist device (LVAD) and Bioheart's MyoCell adult muscle stem cell composition and Bioheart's MyoCath needle tipped catheter delivery system.

9 Dec 2010

OMT announces new human antibody platform using genetically engineered rats expressing human antibodies

Open Monoclonal Technology, Inc. (OMT) today announced its new human antibody platform using the first genetically engineered rats expressing a human antibody repertoire. The company, which also created the first targeted knockout rats in 2009, is now cross-breeding the knockout animals with the rats expressing human antibodies to finalize its platform.

9 Dec 2010

Home health care technology could help patients improve their health, overall well-being: Study

Home health care technology may provide one important solution to global concerns about how to sustain health care systems threatened by rising costs and manpower shortages, but such a change faces multiple obstacles to adoption, according to a new RAND Corporation study.

9 Dec 2010

Anchor Therapeutics announces publication describing pepducin technology as novel approach to target GPCR

Anchor Therapeutics today announced the publication of new research in the Proceedings of the National Academy of Sciences USA. The paper describes the identification and characterization of a pepducin-based allosteric agonist that targets CXCR4, a chemokine G protein-coupled receptor found on hematopoietic stem cells and other bone marrow-derived cells.

9 Dec 2010

Organovo releases data on bioprinted blood vessels

Organovo, Inc., a regenerative medicine company focused on bioprinting technology, today announced the release of data on the first fully bioprinted blood vessels. Data was presented at the Tissue Engineering and Regenerative Medicine International Society (TERMIS) meeting in Orlando, Florida. The blood vessels were created through the use of the NovoGen MMX Bioprinter, Organovo's proprietary platform for the creation of 3D tissue constructs.

9 Dec 2010

WHO endorses rapid TB test

"The World Health Organization endorsed a new, rapid test for tuberculosis Wednesday that cuts the diagnosis time for patients from months to hours," CNN reports (Gray, 12/8).

8 Dec 2010

Myriad to acquire technology for diagnosis, prognosis of malignant melanoma

Myriad Genetics, Inc. today announced that it has signed an agreement to acquire proprietary technology for the diagnosis and prognosis of malignant melanoma using highly validated genetic markers from Melanoma Diagnostics, Inc. of Altadena, California. Under the agreement, Myriad has the right to commercialize all tests derived from the technology on a worldwide basis in exchange for upfront fees and contingent payments based upon the commercial success of the products.

8 Dec 2010

Aetna to acquire health information exchange firm for $500 million

Aetna, one of the largest U.S. insurers, is expanding its health information technology presence with its $500 million acquisition of technology firm Medicity, Bloomberg reports. "Medicity, based in Salt Lake City, offers technology that helps 760 hospitals and 125,000 physicians in the U.S. exchange medical data, according to the statement." Aetna said it financed the deal with "available resources" that wouldn't affect its financial results (Nussbaum, 12/7).

8 Dec 2010

Rapid TB test endorsed by WHO

The World Health Organization (WHO) said that a new test that can detect tuberculosis (TB), including drug-resistant forms, in less than two hours could revolutionize treatment of the disease. Tuberculosis is still a major killer worldwide killing 4,700 people every day last year. The annual death toll of 1.7 million includes 380,000 people who are at particular risk because they have HIV, the virus that depresses the immune system and causes Aids.

8 Dec 2010

ChipDX validates genetic signature for early-stage colon cancer

ChipDX LLC, a New York-based online molecular diagnostics and personalized medicine company, discovered and validated a genetic signature for early-stage colon cancer and is developing an online screening application to enable clinicians to more accurately identify risk of recurrence. In the study, published in the December issue of the British Journal of Cancer, ChipDX demonstrates how the 163-gene signature stratifies colon cancer patients into high- and low-risk groups for recurrence with greater accuracy than current methods.

8 Dec 2010

MedeAnalytics introduces Accountable Care Solution for healthcare provider and payer organizations

MedeAnalytics, a leading provider of healthcare performance management solutions, today announced the launch of its Accountable Care Solution for healthcare provider and payer organizations.

8 Dec 2010

FDA clears Valeritas' V-Go Disposable Insulin Delivery Device

Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that the US Food and Drug Administration has cleared the company's V-Go Disposable Insulin Delivery Device for the continuous subcutaneous delivery of insulin in preset basal rates and with on-demand bolus dosing for adult patients requiring insulin.

8 Dec 2010

Researchers develop imaging technology that can accurately identify prostate cancer

Prostate cancer is the most common type of cancer among men, but its diagnosis has up to now been inaccurate and unpleasant. Researchers at Eindhoven University of Technology in the Netherlands, in cooperation with AMC Amsterdam, have developed an imaging technology that can accurately identify tumors.

8 Dec 2010

First Edition: December 8, 2010

Today's health policy headlines include more detail on the deal reached to avoid a scheduled cut in physician's Medicare pay.

8 Dec 2010

UBC's new formulation of Amphotericin B for Visceral Leishmaniasis remains stable in tropical climates

A new formulation of Amphotericin B (AmB) developed by University of British Columbia researchers has been shown to be stable in tropical climates and effective in treating Visceral Leishmaniasis (VL) in mouse models.

8 Dec 2010

Technology News and Research

Medisafe 1 Technologies demonstrates syringe locking device at Israel's National Ministry of Health

Media examines efforts to protect patients in Africa from counterfeit medications

VIRxSYS presents study results of VRX1116 at HIV DART 2010

Nottingham researchers develop new 'score' to detect heart disease in younger people

Exergen's TemporalScanner demonstrates accuracy in temperature assessment for surgical patients

Bioheart group to advance BRIDGE TO RECOVERY clinical trial

OMT announces new human antibody platform using genetically engineered rats expressing human antibodies

Home health care technology could help patients improve their health, overall well-being: Study

Anchor Therapeutics announces publication describing pepducin technology as novel approach to target GPCR

Organovo releases data on bioprinted blood vessels

WHO endorses rapid TB test

Myriad to acquire technology for diagnosis, prognosis of malignant melanoma

Aetna to acquire health information exchange firm for $500 million

Rapid TB test endorsed by WHO

ChipDX validates genetic signature for early-stage colon cancer

MedeAnalytics introduces Accountable Care Solution for healthcare provider and payer organizations

FDA clears Valeritas' V-Go Disposable Insulin Delivery Device

Researchers develop imaging technology that can accurately identify prostate cancer

First Edition: December 8, 2010

UBC's new formulation of Amphotericin B for Visceral Leishmaniasis remains stable in tropical climates

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News